about
Dyslipidaemia in the Middle East: Current status and a call for actionGender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2).Impact of diabetes on hospital adverse cardiovascular outcomes in acute coronary syndrome patients: Data from the Saudi project of acute coronary events.Disparities in health care delivery and hospital outcomes between non-Saudis and Saudi nationals presenting with acute coronary syndromes in Saudi ArabiaClinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.Patient and System-Related Delays of Emergency Medical Services Use in Acute ST-Elevation Myocardial Infarction: Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps).Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry).Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: Results of the Saudi project for assessment of coronary events (SPACE) registry.Age and its relationship to acute coronary syndromes in the Saudi Project for Assessment of Coronary Events (SPACE) registry: The SPACE age studyThe utility of ambulatory pH monitoring in patients presenting with chronic cough and asthmaAge and clinical outcomes in patients presenting with acute coronary syndromes.Use of emergency medical services in the second gulf registry of acute coronary events.Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East.Atrial Fibrillation in Patients Hospitalized With Heart Failure: Patient Characteristics and Outcomes From the HEARTS Registry.Prevalence, awareness, treatment and control of hypertension in four Middle East countries.Prognostic significance of prevalent and incident atrial fibrillation among patients hospitalized with acute coronary syndrome: findings from the Gulf RACE-2 Registry.The obesity paradox in patients with acute coronary syndrome: results from the Gulf RACE-2 study.Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2.Acute Coronary Syndrome in Indian Subcontinent Patients Residing in the Middle East: Results From Gulf Registry of Acute Coronary Events II.Validation of the Canada Acute Coronary Syndrome Risk Score for Hospital Mortality in the Gulf Registry of Acute Coronary Events-2.Validation of the 6-Month GRACE Score in Predicting 1-Year Mortality of Patients With Acute Coronary Syndrome Admitted to the Arabian Gulf Hospitals.Chronic obstructive airway disease among patients hospitalized with acute heart failure; clinical characteristics, precipitating factors, management and outcome: Observational report from the Middle East.Predictors and Impact of In-Hospital Recurrent Myocardial Infarction in Patients With Acute Coronary Syndrome: Findings From Gulf RACE-2.BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: Findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry.Acute heart failure presentations and outcomes during the fasting month of Ramadan: an observational report from seven middle eastern countries.Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.Development of a mobile phone-based intervention to improve adherence to secondary prevention of coronary heart disease in China.Xylohypha bantiana multiple brain abscesses in a patient with systemic lupus erythematosus.Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE).Attitude of the Saudi community towards heart donation, transplantation, and artificial hearts.Assessment of physicians' awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: Is there a gap?The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.The prognostic impact of in-hospital worsening of renal function in patients with acute coronary syndrome.Clinical Presentation, Predictors, and Outcomes Among Mineralocorticoid Receptor Antagonist (MRA)-Eligible Acute Heart Failure Patients in the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS).Long-Term Mortality Rates in Acute De Novo Versus Acute-on-Chronic Heart Failure: From the Heart Function Assessment Registry Trial in Saudi Arabia.Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61 229 individuals in 21 countries.Using Mobile Health Intervention to Improve Secondary Prevention of Coronary Heart Diseases in China: Mixed-Methods Feasibility Study.Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in Saudi Arabia (HEARTS-chronic).β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).
P50
Q26741558-1C8A5B11-03F8-41E2-8BAE-E72023B82512Q30588507-BA344597-8396-4302-8420-6B8E0D468CDDQ35029330-289D793A-5641-4068-A546-1F9E62E4CCFDQ35447503-79D51559-2CB4-4DFF-8A31-90751C7E14CFQ35539387-572D239B-8B23-4490-9797-9A1880E61B13Q35903032-4C87CBC1-E9F1-4855-B0A6-DDCE2912B03DQ36024237-ABA3B3D3-69E3-418F-A2FB-70A87CDAB273Q37055808-CBD97C89-79F5-4C22-B3F3-AC6550F46BADQ37055848-CF85FABC-4B6D-4731-9086-2DCC0C74C57BQ37133435-79772C75-00D3-4877-AD48-01DA3F08BD87Q37163133-6C5DDDAF-5763-4A78-8003-EDB8150D4467Q38405076-BD325954-D537-44E4-B2F3-665E1305FB8FQ38685401-2AD8EA12-912C-4B4C-8066-BB1E999EB706Q38737823-57942B0E-3691-40D1-B45D-89697BA17085Q38795863-775CBDF5-A19D-4E1D-A0E5-1A4828AB2FF1Q39197016-0C72BF5F-DF89-435D-BD06-086D43BC9255Q39197937-9C3CFD59-688C-412F-8EC2-414FCDC8B90CQ39198319-548DB4DB-3199-433D-B978-2292E4312CECQ39198895-68635E31-8BDE-437A-B49D-159263A781FAQ39199551-B8A0C526-719B-4347-9931-40CA076187A1Q39200459-5C77265D-89B4-4D33-8FEC-3AB0B421FDDEQ39200729-C0DB3F1B-7A77-43D4-870C-EF92C3274A6CQ39200772-1AD6FB7D-76B0-4678-A2B6-042B240FF95CQ39201081-466BE1F7-1B8B-4C9D-9A9A-5A0F358F5B3DQ39201581-31A8B4B6-C642-4E15-90AB-827755980FD6Q39856310-35104DAD-68B4-405B-9033-98F65259E616Q40560295-3BDDD976-2B1F-429D-AC22-6B9C29CC45E8Q40666796-A3E8F0DD-A184-4F64-B976-69B1633FAA73Q41295585-FAED51EF-344A-4461-B2A2-08EF08F1DCDBQ41391225-2E255014-1AA4-422B-8A18-44C2E2D19B96Q41444737-5E2ACDF8-53F3-46D1-BE96-0D394BAE3B7CQ41467514-E9F1B114-D9BA-47C8-BB7E-16DAC37D6260Q44774405-4FAF009F-523D-45DF-BF17-80DD0D497365Q44977372-33450DAD-8C5C-42D0-A31C-65F909270949Q46224521-3CB183BA-0567-4615-A6A3-8941D2C9470EQ46631980-E4D364B2-BD22-4867-96DB-7680E31A7ABBQ47404727-BDA66014-4E2D-4BB3-8BA0-BB78DFD390BDQ48164035-49C2A4C7-02A1-4F3A-8735-352F348B51E4Q48268259-AC1C99B8-107F-4924-AA3A-0DFA046C39A2Q49234909-0E600E5E-5A8C-4E29-889F-27C4F2F74D26
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
K F Alhabib
@en
K F Alhabib
@nl
type
label
K F Alhabib
@en
K F Alhabib
@nl
prefLabel
K F Alhabib
@en
K F Alhabib
@nl
P31
P496
0000-0002-6692-3874